jag009
★★★

NJ,
2015-10-19 22:32
(3478 d 20:58 ago)

Posting: # 15572
Views: 7,576
 

 BE studies for Inhalants [Power / Sample Size]

Post reply
Hi guys,

Question. Has anyone conducted BE (not PD) studies with inhalants? If so, in general how are the intra-subject CVs? No worse than oral BE studies?

Thanks
John
 
ElMaestro
★★★

Denmark,
2015-10-19 22:43
(3478 d 20:47 ago)

@ jag009
Posting: # 15573
Views: 5,929
 

 BE studies for Inhalants

Post reply
Hi Jag,

rule of thumb:
The CV's will be between 18%-32%, but only if you use good CROs.

Inhaler training is important, but nowadays most companies do it quite well. Importantly: Don't rely on in vitro data when executing a pivotal trial and pick only the best CROs.
—
Pass or fail!
ElMaestro
 
BE-proff
●    

2015-10-23 12:32
(3475 d 06:58 ago)

@ jag009
Posting: # 15577
Views: 5,699
 

 BE studies for Inhalants

Post reply
Hi jag,

If it is not a secret what inhalants you are going to investigate in BE studies?;-)
IMHO most of them work locally (esp. for BA and COPD) so it is worth doing therapeutic equivalence study.
Or you medications are for another diseases? :cool:
 
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
108 visitors (0 registered, 108 guests [including 3 identified bots]).
Forum time: 19:31 CEST (Europe/Vienna)

There are two possible outcomes: if the result confirms the
hypothesis, then you’ve made a measurement. If the result is
contrary to the hypothesis, then you’ve made a discovery.    Enrico Fermi

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5